SCHEMBL13201532

SCHEMBL13201532

Cn1nc(-c2ccc(N)c(N)c2)c2c(N)ncnc21

nearest known ligand 0.70

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PIK3CD O00329 14/20 0.70
PIK3CA P42336 14/20 0.70
PIK3CB P42338 14/20 0.70
PIK3CG P48736 14/20 0.70
PRKDC P78527 14/20 0.70
SRC P12931 14/20 0.70
ABL1 P00519 12/20 0.70
EGFR P00533 11/20 0.70
HCK P08631 11/20 0.70
MTOR P42345 11/20 0.70
EPHB4 P54760 11/20 0.70
KDR P35968 10/20 0.70
PI4KB Q9UBF8 4/20 0.68
NUDT14 O95848 1/20 0.61
NUDT5 Q9UKK9 1/20 0.61
AURKA O14965 1/20 0.52
IKBKE Q14164 1/20 0.52
AURKB Q96GD4 1/20 0.52
RET P07949 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23997199 0.89 SRC (0.73) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL30320603 0.88 PIK3CD (0.65) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL21436578 0.88 PIK3CD (0.65) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL23917212 0.88 PIK3CD (0.79) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL30320627 0.88 PIK3CD (0.65) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL21436859 0.88 PIK3CD (0.65) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL130513 0.84 SRC (0.79) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL30782445 0.84 NUDT14 (0.69) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL12366 0.84 NUDT14 (0.69) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC
SCHEMBL130637 0.83 PIK3CD (0.81) PIK3CDPIK3CAPIK3CBPIK3CGPRKDC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7772231-B2 Substituted pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors ABBOTT LABORATORIES (US) 2010-08-10 US disclosed
US-20070203143-A1 PROTEIN KINASE INHIBITORS ABBVIE INC. 2007-08-30 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070203143-A1 PROTEIN KINASE INHIBITORS PACSIN2, MAP3K20, PHKG1 PIK3CD 264/4885PIK3CA 139/4885PIK3CB 155/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.